Trump Nominates Dr. Erica Schwartz as CDC Director
Trump nominates former deputy surgeon general Erica Schwartz to lead CDC, signaling potential shift away from Kennedy's vaccine skepticism.
Objective Facts
President Trump announced Thursday that he was nominating Dr. Erica Schwartz to lead the Centers for Disease Control and Prevention. Rear Adm. Erica G. Schwartz was deputy surgeon general during President Donald Trump's first term. The CDC has been without a permanent director since August after Dr. Susan Monarez, who had been confirmed, was dismissed in August after clashing with Kennedy over vaccine policy. The White House was under a deadline to nominate a permanent director for the CDC, with the federal Vacancies Act limiting how long an acting director can serve. Schwartz is a public health veteran who has led vaccination programs, a new sign of the administration's shifting views on vaccines, with her nomination coming just hours after Kennedy's appearance at a congressional hearing where he made some of his most supportive comments yet on vaccination.
Left-Leaning Perspective
The American Public Health Association welcomed Schwartz's nomination, with Dr. Georges Benjamin, the organization's head, stating the administration 'has identified someone who is highly qualified, and has a demonstrated track record of competence in being both a good physician and a decent manager,' noting that 'Things she's said have clearly been based on good science.' Dr. Demetre Daskalakis, former head of the CDC's National Center for Immunization and Respiratory Diseases who resigned in protest of Kennedy's firing of previous CDC director Susan Monarez, said the team has 'great potential if political interference and the self interest of the secretary of health doesn't hamper their ability to deliver.' Former CDC officials who spoke anonymously to media expressed cautious optimism about Schwartz's support of vaccines, with one saying 'She looks good on paper and should get approved by the Senate,' though questioning whether she will 'defend vaccines as a positive tool for public health.'
Right-Leaning Perspective
Trump announced Schwartz's nomination on Truth Social, calling her 'incredibly talented' and part of efforts to restore 'the GOLD STANDARD OF SCIENCE at the CDC, which was an absolute disaster focused on mandates under Sleepy Joe,' stating 'Together, they will do a TREMENDOUS job.' Dr. Jerome Adams, the top doctor during Trump's first term who personally selected Schwartz as Deputy, said she has 'the expertise, credibility, and integrity to lead the CDC effectively' and that 'If allowed to follow the science without political interference, she'll excel,' expressing cautious optimism. During a House Appropriations Committee hearing, Kennedy said the new CDC team was 'extraordinary,' stating 'I think this new team is really going to be able to revolutionize CDC and get it back on track.'
Deep Dive
Schwartz's nomination reflects a genuine tension within the Trump administration between Health Secretary Robert F. Kennedy Jr.'s vaccine skepticism and the need for Senate confirmation. The timing—announcing Schwartz's nomination hours after Kennedy made some of his most pro-vaccine comments in a congressional hearing about measles vaccine safety—suggests deliberate positioning to signal moderation. The CDC has faced unprecedented leadership instability, with only one permanent director (Monarez) lasting one month after being fired by Kennedy over vaccine policy disagreements. Schwartz appears selected as a compromise: her pro-vaccine background and military credentials appeal to mainstream public health while her prior service under Trump satisfies administration loyalists. Her actual independence remains untested—former CDC officials question whether Schwartz will have real autonomy or face the same constraints as Monarez, noting Kennedy hasn't fundamentally changed his approach. The critical test will be her confirmation hearing before the Senate Health, Education, Labor and Pensions Committee, which has already expressed skepticism about Kennedy's direction during Dr. Casey Means's surgeon general confirmation hearing, where even Republican Chairman Bill Cassidy expressed concerns about vaccine recommendation changes. Schwartz must navigate confirming her scientific credentials without alienating Kennedy's vaccine-skeptic constituency, while administration officials have struggled to find a nominee who can get Senate confirmation without alienating Kennedy's base, which has constituents with strong concerns about approved vaccines.